Effects of alendronate on bone formation and osteoclastic resorption of beta-tricalcium phosphate
نویسندگان
چکیده
Effects of alendronate on bone formation and osteoclastic resorption of beta-tricalcium phosphate Takaaki Tanaka1, Mitsuru Saito2, Yoshio Kumagae1, Masaaki Chazono2, Hirokazu Komaki2, Takahiro Kikuchi1, Seiichiro Kitasato2, Chikara Ushiku2, Hidekazu Hattori2, Keishi Marumo2 1Orthopaedic Surgery, NHO Utsunomiya National Hospital, Utsunomiya, Japan; 2Orthopaedic Surgery, Jikei University, Minato-ku, Japan [email protected]
منابع مشابه
Local Application of Alendronate on β-Tricalcium Phosphate Accelerated Induction of Osteogenesis with Formation of Giant Osteoclast-Like Cell
Intrinsic osteoinductivity—the ability to induce bone formation in ectopic sites without addition of osteogenic factorshas been reported in various porous materials. Tartrate-resistant acid phosphatase (TRAP)-positive osteoclast-like cells are thought to play an important role in material-induced osteoinduction. To investigate the influence of osteoclastic activity on intrinsic osteoinduction, ...
متن کاملBisphosphonates in the treatment of metabolic bone diseases.
Bisphosphonates (BP) are pyrophosphate analogs, P-C-P with various carbon side-chains. The phosphate groups are responsible for the low gastrointestinal absorption (about 1%), limited penetration into cells, adsorption to bone mineral and rapid excretion in the urine. Based on the C side-chains, BPs can inhibit osteoclastic bone resorption with potencies which differ by as much as 10,000-fold a...
متن کاملOsteoblastic responses to TGF-beta during bone remodeling.
Bone remodeling depends on the spatial and temporal coupling of bone formation by osteoblasts and bone resorption by osteoclasts; however, the molecular basis of these inductive interactions is unknown. We have previously shown that osteoblastic overexpression of TGF-beta2 in transgenic mice deregulates bone remodeling and leads to an age-dependent loss of bone mass that resembles high-turnover...
متن کامل0012 - Alendronate Therapy Increases the Mechanical Properties of Canine Trabecular Bone
Introduction: Alendronate, a second generation bisphosphonate, is known to increase bone density by inhibiting osteoclastic bone resorption. It is clincally used to treat osteoporosis, Paget’s disease and hypercalcemia associated with malignancy [1]. In clinical trials and animal studies, the effects are typically quantified by measuring bone mineral density. In this study, we sought to determi...
متن کاملRegulation and enzymatic basis of bone resorption by human osteoclasts.
Although much has been learned recently of the mechanisms that regulate osteoclastic differentiation, much less is known of the means through which their resorptive activity is controlled. This is especially so for human osteoclasts. We have recently developed an assay that allows us to measure resorptive activity while minimizing confounding effects on differentiation by optimizing osteoclasto...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2002